Geode Capital Management’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$214M Buy
2,374,467
+114,821
+5% +$9.73M 0.01% 772
2026
Q1
$189M Buy
2,259,646
+58,414
+3% +$4.79M 0.01% 752
2025
Q4
$202M Buy
2,201,232
+5,671
+0.3% +$543K 0.01% 717
2025
Q3
$208M Buy
2,195,561
+48,383
+2% +$4.55M 0.01% 686
2025
Q2
$225M Buy
2,147,178
+4,386
+0.2% +$416K 0.02% 623
2025
Q1
$189M Buy
2,142,792
+53,394
+3% +$5.48M 0.01% 654
2024
Q4
$201M Buy
2,089,398
+10,421
+0.5% +$971K 0.02% 634
2024
Q3
$170M Buy
2,078,977
+15,145
+0.7% +$1.17M 0.01% 683
2024
Q2
$178M Buy
2,063,832
+88,136
+4% +$7.12M 0.02% 638
2024
Q1
$161M Buy
1,975,696
+82,772
+4% +$6.46M 0.01% 682
2023
Q4
$126M Buy
1,892,924
+84,864
+5% +$5.88M 0.01% 736
2023
Q3
$132M Buy
1,808,060
+64,429
+4% +$4.35M 0.02% 648
2023
Q2
$110M Buy
1,743,631
+100,831
+6% +$5.85M 0.01% 735
2023
Q1
$96.4M Buy
1,642,800
+74,712
+5% +$4.54M 0.01% 769
2022
Q4
$96.7M Buy
1,568,088
+52,080
+3% +$3.5M 0.01% 732
2022
Q3
$102M Buy
1,516,008
+30,974
+2% +$1.96M 0.02% 674
2022
Q2
$91.2M Sell
1,485,034
-496
-0% -$31.8K 0.01% 726
2022
Q1
$100M Buy
1,485,530
+47,140
+3% +$2.55M 0.01% 775
2021
Q4
$63.6M Buy
1,438,390
+23,466
+2% +$1.37M 0.01% 1123
2021
Q3
$91.6M Sell
1,414,924
-10,386
-0.7% -$721K 0.01% 852
2021
Q2
$115M Buy
1,425,310
+62,468
+5% +$4.76M 0.02% 721
2021
Q1
$92.7M Buy
1,362,842
+180,176
+15% +$14.2M 0.01% 799
2020
Q4
$82.4M Buy
1,182,666
+58,385
+5% +$3.63M 0.01% 788
2020
Q3
$57.8M Buy
1,124,281
+57,033
+5% +$3.13M 0.01% 844
2020
Q2
$62.6M Sell
1,067,248
-21,139
-2% -$1.17M 0.01% 770
2020
Q1
$55.1M Buy
1,088,387
+75,714
+7% +$5.03M 0.01% 724
2019
Q4
$75M Sell
1,012,673
-87,373
-8% -$5.45M 0.02% 728
2019
Q3
$62.9M Buy
1,100,046
+178,963
+19% +$11.9M 0.01% 769
2019
Q2
$60.2M Buy
921,083
+251,629
+38% +$17.5M 0.01% 781
2019
Q1
$49.5M Buy
669,454
+42,095
+7% +$2.96M 0.01% 846
2018
Q4
$37.4M Buy
627,359
+60,027
+11% +$4.84M 0.01% 877
2018
Q3
$53.6M Buy
567,332
+32,624
+6% +$2.81M 0.02% 767
2018
Q2
$40.2M Buy
534,708
+65,223
+14% +$4.68M 0.01% 884
2018
Q1
$28.4M Buy
469,485
+9,644
+2% +$522K 0.01% 1024
2017
Q4
$21.5M Sell
459,841
-12,158
-3% -$602K 0.01% 1218
2017
Q3
$23.9M Buy
471,999
+78,429
+20% +$3.65M 0.01% 1109
2017
Q2
$19.6M Buy
393,570
+28,169
+8% +$1.32M 0.01% 1198
2017
Q1
$15.5M Buy
365,401
+25,187
+7% +$1.11M 0.01% 1340
2016
Q4
$13.8M Buy
340,214
+38,168
+13% +$1.48M 0.01% 1370
2016
Q3
$11.4M Buy
302,046
+30,230
+11% +$958K 0.01% 1405
2016
Q2
$8.26M Buy
271,816
+14,707
+6% +$386K ﹤0.01% 1575
2016
Q1
$6.34M Buy
257,109
+25,859
+11% +$554K ﹤0.01% 1710
2015
Q4
$5.8M Buy
231,250
+3,440
+2% +$106K ﹤0.01% 1774
2015
Q3
$6.73M Buy
227,810
+3,092
+1% +$97.2K ﹤0.01% 1635
2015
Q2
$7.2M Buy
224,718
+147,173
+190% +$3.95M ﹤0.01% 1648
2015
Q1
$1.94M Buy
77,545
+8,221
+12% +$178K ﹤0.01% 2463
2014
Q4
$1.76M Buy
69,324
+32,377
+88% +$702K ﹤0.01% 2505
2014
Q3
$676K Buy
+36,947
New +$709K ﹤0.01% 3015

Other funds holding HQY

Geode Capital Management's HQY Position: Q2 2026 in Review

Geode Capital Management increased its HealthEquity (HQY) stake by 5.1% in Q2 2026, buying an estimated $9.73M and bringing the position to 2,374,467 shares worth $214M. The position accounts for 0.01% of the portfolio, ranked #772.

Geode Capital Management first reported a position in HQY in Q3 2014 and has held it in 48 quarters since. The position peaked at $225M in Q2 2025. 498 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Geode Capital Management held 2,374,467 shares of HealthEquity worth $214M as of Q2 2026.
  • Geode Capital Management bought 114,821 HealthEquity shares in Q2 2026, an estimated $9.73M.
  • HealthEquity made up 0.01% of Geode Capital Management's portfolio in Q2 2026, its #772 holding.
  • Geode Capital Management first reported a position in HealthEquity in Q3 2014 and has held it in 48 quarters since.
  • Geode Capital Management's HealthEquity position peaked at $225M in Q2 2025.
  • 498 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.